Diagnosis Drift and Its Contribution to Polypharmacy

Area of Science:

• Geriatric Medicine
• Clinical Pharmacology
• Public Health

Background:

• Medical practice increasingly diagnoses milder conditions, leading to a rise in prescribed medications.
• This trend elevates the risk of polypharmacy, particularly among elderly patients managing multiple comorbidities.
• Polypharmacy presents significant challenges in healthcare delivery and patient outcomes.

Purpose of the Study:

• To analyze the implications of expanding diagnoses on medication regimens.
• To highlight the risks and adverse consequences associated with polypharmacy.
• To advocate for a selective treatment approach to mitigate polypharmacy.

Main Methods:

• Review of diagnostic trends in drug-treatable illnesses.
• Analysis of polypharmacy prevalence and associated risk factors in elderly populations.
• Evaluation of the adverse consequences stemming from polypharmacy.

Main Results:

• Increased diagnosis of milder conditions contributes to higher drug prescriptions per individual.
• Elderly individuals with multiple conditions are at heightened risk of experiencing polypharmacy.
• Adverse outcomes of polypharmacy include elevated healthcare costs, medication confusion, adverse drug events, and adherence issues.

Conclusions:

• The expansion of diagnoses for treatable conditions necessitates a re-evaluation of treatment thresholds.
• Minimizing polypharmacy through judicious treatment decisions is crucial for patient safety and healthcare efficiency.
• A "what not to treat" approach can effectively reduce the burden of polypharmacy and its negative sequelae.